Company profile
Impeto Medical is a privately owned medical device company formed in June 2005 with its corporate headquarters in Paris, France. Impeto Medical manufactures and markets devices designed for non-invasive assessment of eccrine sweat gland activity.
Impeto Medical has developed a technology that assesses sudomotor function.
Based on this technology, Impeto Medical has developed EZSCAN, a device that allows the detection of diabetes risk.
Impeto Medical has recently launched SUDOSCAN+, a device for the diagnosis and follow-up of diabetes complications.
A clinical study on diabetic neuropathy has been funded through FEDER (Fonds Européen de Développement Régional, European Regional Development Fund).
Our mission
Our goal is to provide the medical community with screening tests to face epidemically spreading metabolic disorders and their complications. By providing less invasive, faster and less costly procedures, we enable physicians to screen larger patient populations and to detect diseases and complications earlier.
We build value for our investors through constant innovation based on clinical research as well as focus on priority medical issues.
Lien RSS